Loading
PD
PT Diastika Biotekindo Tbk Stock: price and insider trades · Indonesia
No insider purchase over the last 90 days. The latest, by Franciscus Xaverius Yoshua Raintjung, was filed 07 Aug 2025.
PT Diastika Biotekindo Tbk: what insiders have been doing
PT Diastika Biotekindo Tbk is a Health Care company. Its directors and officers file their transactions with OJK / IDX. Nothing new has been filed by managers of PT Diastika Biotekindo Tbk in twelve months, the latest record being from 7 August 2025.
Our records for PT Diastika Biotekindo Tbk go back to 2025, with 2 purchases and 2 sales on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by OJK / IDX. They describe what insiders did and are not a recommendation.
Insider Decl.
4
Thresholds
n/a
Buy Volume
€170
2 ops. · all time
Sell Volume
€216
2 ops. · all time
Who traded when
BuySaleFranciscus Xaverius Yoshua Raintjung2 buys2 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
IDR 99.00
Analyst consensus
Income statement
EBITDAIDR 33.8B
Valuation
P/Book2.0x
Balance sheet & cash
Market capIDR 407.2B
Debt / Equity11%
Profitability & ownership
ROE8.2%
ROA6.0%
% insiders79.0%
% institutions0.0%
Last declaration on 7 August 2025
Declarations4 total
10,000 shares@ IDR 210.0028.9% of flowIDXIDX:039-DIR-DB-VIII-2025-CHEK#2
10,000 shares@ IDR 195.0027.0% of flowIDXIDX:039-DIR-DB-VIII-2025-CHEK#3
10,000 shares@ IDR 158.0021.7% of flowIDXIDX:039-DIR-DB-VIII-2025-CHEK#0
Canonical exit: 9 Oct 2025 (T+90)
10,000 shares@ IDR 162.0022.3% of flowIDXIDX:039-DIR-DB-VIII-2025-CHEK#1
Canonical exit: 9 Oct 2025 (T+90)
4 of 4 declarations
About PT Diastika Biotekindo Tbk
PT Diastika Biotekindo Tbk is a publicly traded company on the Indonesia Stock Exchange, specializing in the biotechnology sector. It focuses on developing innovative solutions in the field of biotechnology.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations